Helix Biomedix (United States)

Recent papers from Helix Biomedix (United States)

1. Structural dynamics of kappa opioid receptor interactions with β-arrestin 1Nature Communications · 2026
2. Upfront ultrafast multigene panel testing for NCCN guideline–recommended biomarker detection in advanced NSCLC.Journal of Clinical Oncology · 2026
3. Validation of a droplet digital PCR test for monitoring ESR1 ctDNA variants in blood.Journal of Clinical Oncology · 2026
4. Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxelJournal for ImmunoTherapy of Cancer · 2025
5. Validation of a High-Specificity Blood Autoantibody Test to Detect Lung Cancer in Pulmonary NodulesCHEST Pulmonary · 2024
6. B-242 Improved Patient Satisfaction With Novel Capillary Blood Collection Devices as an Alternative to Venipuncture for Applications in Clinical Proteomic AssaysClinical Chemistry · 2024
7. The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancerCancer · 2024
8. Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and StagesDiagnostics · 2024
9. Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19Nature · 2023
10. Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidanceJournal of Mass Spectrometry and Advances in the Clinical Lab · 2023
11. Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP192023
12. STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary AngioedemaJournal of Pharmacology and Experimental Therapeutics · 2023
13. Assessing a biomarker’s ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE studyPLoS ONE · 2023
14. Using a Blood Biomarker to Distinguish Benign From Malignant Pulmonary NodulesCHEST Journal · 2023
15. Molecular & Translational Biology of the Blood-Based VeriStrat® Proteomic Test Used in Cancer Immunotherapy Treatment Guidance2022
16. Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular DiagnosticsMolecules · 2022
17. Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers2022
18. Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization ProjectAnnals of Oncology · 2021
19. Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerJournal for ImmunoTherapy of Cancer · 2021
20. Predicting prognosis in COVID-19 patients using machine learning and readily available clinical dataInternational Journal of Medical Informatics · 2021